BackAIM ImmunoTech Overview

AIM ImmunoTech Current Cash

Track AIM ImmunoTech's current cash ($9.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$9.90M
↑ 1979.83% YoYΔ $9.42M vs prior year quarter

Peer trimmed avg / median

Loading

AIM ImmunoTech Current Cash History

Loading

AIM ImmunoTech vs. peers: Current Cash Comparison

Loading

AIM ImmunoTech Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AIM ImmunoTech (AIM) FAQ

As of the most recent data (June 2026), AIM shows a current cash of $9.9M. That compares with $480K in the prior-year period — up 1979.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AIM's current cash is now $9.9M (was $480K) — a 1979.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether AIM ImmunoTech is outperforming or lagging.

Tracking AIM's current cash over time shows whether AIM ImmunoTech is scaling, shrinking, or reshaping that part of the business. The current reading is $9.9M That compares with $480K in the prior-year period — up 1979.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has AIM ImmunoTech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $9.9M) with ownership activity and broader fundamentals.

AIM ImmunoTech's current cash is $9.9M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.